Piramal Healthcare Limited to Acquire Decision Resources Group

May 16, 2012

• Decision Resources Group (DRG) acquisition at approximately US$635 Million
• DRG a fast growing healthcare information business - CAGR 20% from 2006 to 2011
• DRG’s client base includes 48 out of top 50 global pharma companies

Decision Resources Group to Convene Panel of Healthcare Experts at its Market Access Seminar in New York

May 7, 2012

One-Day Event to Address Healthcare Market Drivers and OpportunitiesRead More

Pharma Reps Can Now Access Formulary Data Anytime, Anywhere

April 19, 2012

iPad® Applications Allow Access to Real-Time Formulary Data by State, Health Plan, Drug Class or Drug Name
Read More

Decision Resources data quoted in In Vivo

May 2, 2012

MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?
Two new oral drugs for relapsing remitting multiple sclerosis are poised for a near-term launch, and more drugs that work through different mechanisms of action could soon follow.
Read More

Manhattan Research data quoted in iHealthBeat

April 18, 2012

How Many Times Per Month Do Certain Types of Patients Seek Online Health Information?
U.S. adults with multiple sclerosis go online to look up health information about seven times per month, according to a survey by Manhattan Research.
Read More

BioTrends Research Group Therapeutic Class Director Dan Winkelman quoted on Genomeweb

April 18, 2012

ALK Mutation Testing for NSCLC on the Rise among Oncologists, BioTrends Survey Finds
A recent survey tracking the adoption of ALK mutation testing among oncologists suggests that doctors are becoming increasingly comfortable personalizing treatment strategies for non-small cell lung cancer patients based on clinical factors and genomic data.
Read More

Seminar: Competitive Landscape Seminar Series: Cardiovascular

June 22, 2012 to June 22, 2012

This one-day seminar analyzes global cardiovascular treatment markets from both pharmaceutical and medical device perspectives.Read More

Seminar: Competitive Landscape Seminar Series: Market Access

May 17, 2012 to May 17, 2012

This exciting one-day seminar will feature comprehensive analysis of current and future trends in managed markets to help you understand and maximize opportunities. Expert analysts from Decision Resources Group will cover a range of industry issues, addressing the hottest topics in market access.Read More

Analyst Call: Atrial Fibrillation: Will Emerging Agents With Novel Mechanisms of Action Overcome the Limitations of Current Treatments? - On Demand

August 16, 2011 to August 16, 2011

Based on our Pharmacor Atrial Fibrillation advisory service, Decision Resources is offering an exclusive analyst call entitled Atrial Fibrillation: Will Emerging Agents With Novel Mechanisms of Action Overcome the Limitations of Current Treatments?

This analyst call was held on August 16, 2011. Contact us to learn how you can purchase this service and access the recorded event.

Click here to view the invite.
Read More